By
MikeH on
September 13, 2012
If I were the parent of a child with diabetes, my opinions about the new-to-the-market and highly praised Medtronic MySentry CGM monitoring device might be different.
But I’m not a CWD parent. No, I’m an adult living with type 1 diabetes.
And from that perspective, despite all the benefits of this device I see, it’s just not for me. I see more cons and downsides to it than benefits and that’s why I can’t say…
Read more »
By
MikeH on
September 12, 2012
A controversial TechCrunch post recently declared: we may no longer need doctors, just algorithms. I don’t know about that, but as a person struggling with a chronic condition each day, I think we mostly need each other.
I’m convinced that I am healthier because I’m active in the diabetes online community. Thanks to the wonders of social media and online networking, I have a better handle on my D-management than I would if I weren’t…
Read more »
By
MikeH on
September 11, 2012
Today we’re marking National Invisible Chronic Illness Awareness Week, a worldwide effort to bring together people who live with unseen chronic conditions by sharing their stories. Running through Sunday, Sept. 16, this annual online initiative is now celebrating its first-decade anniversary.
A year ago, I shared a simple message: My diabetes can be visible on my own terms, so if I want to wear it on my sleeve, that’s my choice. But if I choose…
Read more »
By
MikeH on
September 11, 2012
Standing in the corner of a dark room, my eyes took a few moments to adjust to the darkness.
Ten feet in front of me, my mom sat at an eye-testing device the size of an oven. Next to her, a doctor stared at a dimmed screen, with two boxes displayed — one had a close-up of my mom’s right eye showing the inside crosshairs and the other resembled a line graph of what an eye-based…
Read more »
By
WilD on
September 10, 2012
What would you say if someone offered you a safe pill that could lower your blood sugar, help you lose weight, preserve beta cell function, and keep Alzheimer’s at bay?
Actually, that’s the wrong question. The question isn’t what you would say, but what would you pay?
That’s likely the question that was on the boardroom table at bio-tech firm Metabolic Solutions Development Company (MSDC), when they bet the $55-million farm on their pair of…
Read more »